Kir1.1

1

Swale DR et al. ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium Channels.
ACS Chem Neurosci, 2016 May 24 , ().

2

Su XT et al. Disruption of KCNJ10 (Kir4.1) stimulates the expression of ENaC in the collecting duct.
Am. J. Physiol. Renal Physiol., 2016 May 1 , 310 (F985-93).

3

Dong K et al. ROMK1 Knockout Mice Do Not Produce Bartter's Phenotype But Exhibit Impaired K Excretion.
J. Biol. Chem., 2016 Jan 4 , ().

4

Andrikopoulos S et al. Identification of ABCC8 as a contributory gene to impaired early-phase insulin secretion in NZO mice.
J. Endocrinol., 2016 Jan , 228 (61-73).

5

Kuhn M et al. Rare KCNJ18 variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients.
J. Neurol. Neurosurg. Psychiatr., 2016 Jan , 87 (49-52).

6

McMillan T et al. Neonatal diabetes and protein losing enteropathy: a case report.
BMC Med. Genet., 2016 , 17 (32).

7

Zaragoza MV et al. Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.
PLoS ONE, 2016 , 11 (e0155421).

8

de Baaij JH et al. P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis.
PLoS ONE, 2016 , 11 (e0156803).

9

Nikitin AG et al. [Association of the polymorphisms of the FTO, KCNJ11, SLC30A8 and CDKN2B genes with type 2 diabetes].
Mol. Biol. (Mosk.), 2015 Jan-Feb , 49 (119-28).

10

Sitprija V et al. Animal toxins and renal ion transport: Another dimension in tropical nephrology.
Nephrology (Carlton), 2015 Sep 30 , ().

11

Furukawa F et al. In vivo and in vitro effects of high-K(+) stress on branchial expression of ROMKa in seawater-acclimated Mozambique tilapia.
Comp. Biochem. Physiol., Part A Mol. Integr. Physiol., 2015 Sep , 187 (111-8).

12

Wang L et al. Caveolin-1 Deficiency Inhibits the Basolateral K+ Channels in the Distal Convoluted Tubule and Impairs Renal K+ and Mg2+ Transport.
J. Am. Soc. Nephrol., 2015 Nov , 26 (2678-90).

13

Qian Y et al. Joint effect of CENTD2 and KCNQ1 polymorphisms on the risk of type 2 diabetes mellitus among Chinese Han population.
Mol. Cell. Endocrinol., 2015 May 15 , 407 (46-51).

14

Bonfanti DH et al. ATP-dependent potassium channels and type 2 diabetes mellitus.
Clin. Biochem., 2015 May , 48 (476-82).

15

Swale DR et al. Computational and Functional Analyses of a Small-Molecule Binding Site in ROMK.
Biophys. J., 2015 Mar 10 , 108 (1094-103).

16

Chan KH et al. Genetic Variations in Magnesium-Related Ion Channels May Affect Diabetes Risk among African American and Hispanic American Women.
J. Nutr., 2015 Mar , 145 (418-24).

17

Khan AO et al. A distinct vitreo-retinal dystrophy with early-onset cataract from recessive KCNJ13 mutations.
Ophthalmic Genet., 2015 Mar , 36 (79-84).

18

Harel S et al. Alternating hypoglycemia and hyperglycemia in a toddler with a homozygous p.R1419H ABCC8 mutation: an unusual clinical picture.
J. Pediatr. Endocrinol. Metab., 2015 Mar , 28 (345-51).

19

Dai AI et al. Contribution of KCNJ10 gene polymorphisms in childhood epilepsy.
J. Child Neurol., 2015 Mar , 30 (296-300).

20

Zhang C et al. KCNJ10 (Kir4.1) is expressed in the basolateral membrane of the cortical thick ascending limb.
Am. J. Physiol. Renal Physiol., 2015 Jun 1 , 308 (F1288-96).

21

Zhuang L et al. The E23K and A190A variations of the KCNJ11 gene are associated with early-onset type 2 diabetes and blood pressure in the Chinese population.
Mol. Cell. Biochem., 2015 Jun , 404 (133-41).

22

Khawash P et al. Nifedipine in Congenital Hyperinsulinism - A Case Report.
J Clin Res Pediatr Endocrinol, 2015 Jun , 7 (151-4).

23

Walsh SP et al. Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.
ACS Med Chem Lett, 2015 Jul 9 , 6 (747-52).

24

Liu BC et al. Lovastatin-Induced Phosphatidylinositol-4-Phosphate 5-Kinase Diffusion from Microvilli Stimulates ROMK Channels.
J. Am. Soc. Nephrol., 2015 Jul , 26 (1576-87).

25

Zhang M et al. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
J. Pediatr. Endocrinol. Metab., 2015 Jul , 28 (877-84).

26

Vucic E et al. Kir1.1 (ROMK) and Kv7.1 (KCNQ1/KvLQT1) are essential for normal gastric acid secretion: importance of functional Kir1.1.
Pflugers Arch., 2015 Jul , 467 (1457-68).

27

Thurber BW et al. Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes.
Diabetologia, 2015 Jul , 58 (1430-5).

28

Pattnaik BR et al. A Novel KCNJ13 Nonsense Mutation and Loss of Kir7.1 Channel Function Causes Leber Congenital Amaurosis (LCA16).
Hum. Mutat., 2015 Jul , 36 (720-7).

29

Chen J et al. [EAST/SeSAME syndrome and functional expression of inward rectifier potassium channel Kir4.1 in the inner ear].
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2015 Jul , 29 (1318-22).

30

Gleason CE et al. mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity.
J. Clin. Invest., 2015 Jan , 125 (117-28).

31

de Bruijn PI et al. P2X receptors trigger intracellular alkalization in isolated perfused mouse medullary thick ascending limb.
Acta Physiol (Oxf), 2015 Jan , 213 (277-84).

32

Wright PD et al. A High-Throughput Electrophysiology Assay Identifies Inhibitors of the Inwardly Rectifying Potassium Channel Kir7.1.
J Biomol Screen, 2015 Feb 5 , ().

33

Gong C et al. Congenital hyperinsulinism in Chinese patients: 5-yr treatment outcome of 95 clinical cases with genetic analysis of 55 cases.
Pediatr Diabetes, 2015 Feb 2 , ().

34

Guo Z et al. KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma.
Tumour Biol., 2015 Feb , 36 (1251-9).

35

Bertram KL et al. Ion channel expression and function in normal and osteoarthritic human synovial fluid progenitor cells.
Channels (Austin), 2015 Dec 2 , (1-10).

36

Slaats GG et al. Screen-based identification and validation of four new ion channels as regulators of renal ciliogenesis.
J. Cell. Sci., 2015 Dec 15 , 128 (4550-9).

37

Baier LJ et al. ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 Diabetes.
Diabetes, 2015 Dec , 64 (4322-32).

38

Rozenkova K et al. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
J. Clin. Endocrinol. Metab., 2015 Dec , 100 (E1540-9).

39

Yuan J et al. Potassium channel KCNJ15 is required for histamine-stimulated gastric acid secretion.
Am. J. Physiol., Cell Physiol., 2015 Aug 15 , 309 (C264-70).

40

Henn MC et al. Adenosine Triphosphate-Sensitive Potassium Channel Kir Subunits Implicated in Cardioprotection by Diazoxide.
J Am Heart Assoc, 2015 Aug , 4 (e002016).

41

Lin DH et al. Src-family protein tyrosine kinase phosphorylates WNK4 and modulates its inhibitory effect on KCNJ1 (ROMK).
Proc. Natl. Acad. Sci. U.S.A., 2015 Apr 7 , 112 (4495-500).

42

Zúñiga-García V et al. Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development.
Dig. Dis. Sci., 2015 Apr 5 , ().

43

Peña-Almazan S Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation.
Diabetes Res. Clin. Pract., 2015 Apr , 108 (e18-20).

44

Nakajima K et al. KCNJ15/Kir4.2 couples with polyamines to sense weak extracellular electric fields in galvanotaxis.
Nat Commun, 2015 , 6 (8532).

45

Rohdin C et al. A KCNJ10 mutation previously identified in the Russell group of terriers also occurs in Smooth-Haired Fox Terriers with hereditary ataxia and in related breeds.
Acta Vet. Scand., 2015 , 57 (26).

46

Sokolova EA et al. Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) Association in Russian Diabetes Mellitus 2 Type Cohort and Meta-Analysis.
PLoS ONE, 2015 , 10 (e0124662).

47

Kim SH et al. Electrogenic transport and K(+) ion channel expression by the human endolymphatic sac epithelium.
Sci Rep, 2015 , 5 (18110).

48

Doupnik CA et al. A computational design approach for virtual screening of peptide interactions across K(+) channel families.
Comput Struct Biotechnol J, 2015 , 13 (85-94).

49

Cazals Y et al. KCNK5 channels mostly expressed in cochlear outer sulcus cells are indispensable for hearing.
Nat Commun, 2015 , 6 (8780).

50

Haghvirdizadeh P et al. KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus.
J Diabetes Res, 2015 , 2015 (908152).

51

Lee BH et al. Three novel pathogenic mutations in KATP channel genes and somatic imprinting alterations of the 11p15 region in pancreatic tissue in patients with congenital hyperinsulinism.
Horm Res Paediatr, 2015 , 83 (204-10).

52

Sackin H et al. Direct injection of cell-free Kir1.1 protein into Xenopus oocytes replicates single-channel currents derived from Kir1.1 mRNA.
Channels (Austin), 2015 , 9 (196-9).

53

Arai E et al. Ablation of Kcnj10 expression in retinal explants revealed pivotal roles for Kcnj10 in the proliferation and development of Müller glia.
Mol. Vis., 2015 , 21 (148-59).

54

Martelli A et al. Inhibitors of the renal outer medullary potassium channel: a patent review.
Expert Opin Ther Pat, 2015 , 25 (1035-51).

55

Kharade SV et al. ROMK (Kir1.1) pharmacology comes of age.
Channels (Austin), 2015 , 9 (119-20).

56

Senniappan S et al. Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia.
BMC Res Notes, 2015 , 8 (350).

57

Li X et al. The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.
BMC Neurol, 2015 , 15 (38).

58

Villanueva S et al. Cleft Palate, Moderate Lung Developmental Retardation and Early Postnatal Lethality in Mice Deficient in the Kir7.1 Inwardly Rectifying K+ Channel.
PLoS ONE, 2015 , 10 (e0139284).

59

Guo Y et al. Common variants of KCNJ10 are associated with susceptibility and anti-epileptic drug resistance in Chinese genetic generalized epilepsies.
PLoS ONE, 2015 , 10 (e0124896).

60

Baturin AK et al. [The study of the association of polymorphism rs5219 gene KCNJ11 with obesity and the risk of type 2 diabetes among residents of the Moscow Region].
Vopr Pitan, 2015 , 84 (4-9).

61

Liu NJ et al. An analysis of the association between a polymorphism of KCNJ11 and diabetic retinopathy in a Chinese Han population.
Eur. J. Med. Res., 2015 , 20 (3).

62

Zhong H et al. CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes.
Sci Rep, 2015 , 5 (8366).

63

Gilliam D et al. A homozygous KCNJ10 mutation in Jack Russell Terriers and related breeds with spinocerebellar ataxia with myokymia, seizures, or both.
J. Vet. Intern. Med., 2014 May-Jun , 28 (871-7).

64

Jindal R et al. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
Diabetes Metab Syndr, 2014 Jan-Mar , 8 (45-7).

65

Abujbara MA et al. Permanent neonatal diabetes mellitus in Jordan.
J. Pediatr. Endocrinol. Metab., 2014 Sep , 27 (879-83).

66

Jahnavi S et al. Novel ABCC8 (SUR1) gene mutations in Asian Indian children with congenital hyperinsulinemic hypoglycemia.
Ann. Hum. Genet., 2014 Sep , 78 (311-9).

67

Parvizi Z et al. Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation.
Mol. Biol. Rep., 2014 Sep , 41 (6063-9).

68

Lee CH et al. Pregabalin activates ROMK1 channels via cAMP-dependent protein kinase and protein kinase C.
Eur. J. Pharmacol., 2014 Oct 5 , 740 (35-44).

69

Wang L et al. Kcnj10 is a major type of K+ channel in mouse corneal epithelial cells and plays a role in initiating EGFR signaling.
Am. J. Physiol., Cell Physiol., 2014 Oct 15 , 307 (C710-7).

70

Wei Y et al. Angiotensin II type 2 receptor regulates ROMK-like K⁺ channel activity in the renal cortical collecting duct during high dietary K⁺ adaptation.
Am. J. Physiol. Renal Physiol., 2014 Oct 1 , 307 (F833-43).

71

Benrahma H et al. Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.
Biochem. Genet., 2014 Oct , 52 (430-42).

72

Li Q et al. KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients.
Clin. Exp. Pharmacol. Physiol., 2014 Oct , 41 (748-54).

73

Zhuo JL AT2 receptors in cortical collecting ducts: a novel role in mediating ROMK-like K(+) channel responses to high dietary K(+)?
Am. J. Physiol. Renal Physiol., 2014 Nov 15 , 307 (F1134-5).

74

Thewjitcharoen Y et al. Permanent neonatal diabetes misdiagnosed as type 1 diabetes in a 28-year-old female: a life-changing diagnosis.
Diabetes Res. Clin. Pract., 2014 Nov , 106 (e22-4).

75

Kalaivanan P et al. Chromosome 6q24 transient neonatal diabetes mellitus and protein sensitive hyperinsulinaemic hypoglycaemia.
J. Pediatr. Endocrinol. Metab., 2014 Nov , 27 (1065-9).

76

Maiorana A et al. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
Clin. Endocrinol. (Oxf), 2014 Nov , 81 (679-88).

77

Zhu X et al. Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study.
J. Nutr., 2014 Nov , 144 (1734-41).

78

Anık A et al. A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis.
J. Pediatr. Endocrinol. Metab., 2014 May , 27 (533-7).

79

Sang Y et al. KCNJ11 gene mutation analysis on nine Chinese patients with type 1B diabetes diagnosed before 3 years of age.
J. Pediatr. Endocrinol. Metab., 2014 May , 27 (519-23).

80

Doneray H et al. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene.
J. Pediatr. Endocrinol. Metab., 2014 Mar , 27 (367-71).

81

Nwaobi SE et al. DNA methylation functions as a critical regulator of Kir4.1 expression during CNS development.
Glia, 2014 Mar , 62 (411-27).

82

Turki A et al. Gender-dependent associations of CDKN2A/2B, KCNJ11, POLI, SLC30A8, and TCF7L2 variants with type 2 diabetes in (North African) Tunisian Arabs.
Diabetes Res. Clin. Pract., 2014 Mar , 103 (e40-3).

83

Bollepalli MK et al. State-Dependent Network Connectivity Determines Gating in a K(+) Channel.
Structure, 2014 Jun 24 , ().

84

Cheung So E et al. High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells.
Eur. J. Pharmacol., 2014 Jun 11 , ().

85

Li HX et al. GATA-4 induces changes in electrophysiological properties of rat mesenchymal stem cells.
Biochim. Biophys. Acta, 2014 Jun , 1840 (2060-9).

86

Zhang H et al. Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy.
Anesthesiology, 2014 Jun , 120 (1463-75).

87

Demirbilek H et al. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
Eur. J. Endocrinol., 2014 Jun , 170 (885-92).

88

Abdelhamid I et al. E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population.
Prim Care Diabetes, 2014 Jul , 8 (171-5).

89

Cooper PE et al. Cantú syndrome resulting from activating mutation in the KCNJ8 gene.
Hum. Mutat., 2014 Jul , 35 (809-13).

90

Lang F et al. Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1.
Mol. Membr. Biol., 2014 Jan 14 , ().

91

Lin DH et al. MicroRNA-194 (miR-194) regulates ROMK channel activity by targeting intersectin 1.
Am. J. Physiol. Renal Physiol., 2014 Jan 1 , 306 (F53-60).

92

Garcia ML et al. Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis.
J. Pharmacol. Exp. Ther., 2014 Jan , 348 (153-64).

93

Welling PA Rare mutations in renal sodium and potassium transporter genes exhibit impaired transport function.
Curr. Opin. Nephrol. Hypertens., 2014 Jan , 23 (1-8).

94

Xia XH et al. [Effects of E23K polymorphism in KCNJ11 gene on membrane current].
Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2014 Jan , 30 (23-6).

95

Phani NM et al. Genetic association of KCNJ10 rs1130183 with seizure susceptibility and computational analysis of deleterious non-synonymous SNPs of KCNJ10 gene.
Gene, 2014 Feb 25 , 536 (247-53).

96

Glaudemans B et al. A primary culture system of mouse thick ascending limb cells with preserved function and uromodulin processing.
Pflugers Arch., 2014 Feb , 466 (343-56).

97

Huang L et al. Nephrocalcinosis as adult presentation of Bartter syndrome type II.
Neth J Med, 2014 Feb , 72 (91-3).

98

Furukawa F et al. Gene expression and cellular localization of ROMKs in the gills and kidney of Mozambique tilapia acclimated to fresh water with high potassium concentration.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2014 Dec 1 , 307 (R1303-12).

99

Arya VB et al. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations.
Eur. J. Endocrinol., 2014 Dec , 171 (685-95).

100

Myngheer N et al. Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.
Diabetes Care, 2014 Dec , 37 (3333-5).

101

Carmody D et al. Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons.
J. Clin. Endocrinol. Metab., 2014 Dec , 99 (E2709-14).

102

Zhang C et al. KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1).
Proc. Natl. Acad. Sci. U.S.A., 2014 Aug 12 , 111 (11864-9).

103

Lahmann C et al. A mutation causing increased KATP channel activity leads to reduced anxiety in mice.
Physiol. Behav., 2014 Apr 22 , 129 (79-84).

104

Chen J et al. The role of an inwardly rectifying K(+) channel (Kir4.1) in the inner ear and hearing loss.
Neuroscience, 2014 Apr 18 , 265 (137-46).

105

Chang WL et al. A novel mutation of KCNJ11 gene in a patient with permanent neonatal diabetes mellitus.
Diabetes Res. Clin. Pract., 2014 Apr , 104 (e29-32).

106

Albaqumi M et al. A syndrome of congenital hyperinsulinism and rhabdomyolysis is caused by KCNJ11 mutation.
J. Med. Genet., 2014 Apr , 51 (271-4).

107

Klen J et al. CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients.
Eur. J. Clin. Pharmacol., 2014 Apr , 70 (421-8).

108

Wen D et al. Interacting influence of diuretics and diet on BK channel-regulated K homeostasis.
Curr Opin Pharmacol, 2014 Apr , 15 (28-32).

109

Lasram K et al. Evidence for association of the E23K variant of KCNJ11 gene with type 2 diabetes in Tunisian population: population-based study and meta-analysis.
Biomed Res Int, 2014 , 2014 (265274).

110

Sastre J et al. Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.
Diabetes Care, 2014 , 37 (e55-6).

111

Qiu L et al. Quantitative assessment of the effect of KCNJ11 gene polymorphism on the risk of type 2 diabetes.
PLoS ONE, 2014 , 9 (e93961).

112

Juang JM et al. Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome.
Sci Rep, 2014 , 4 (6733).

113

Phani NM et al. Population specific impact of genetic variants in KCNJ11 gene to type 2 diabetes: a case-control and meta-analysis study.
PLoS ONE, 2014 , 9 (e107021).

114

Zhao J et al. KCNJ10 may not be a contributor to nonsyndromic enlargement of vestibular aqueduct (NSEVA) in Chinese subjects.
PLoS ONE, 2014 , 9 (e108134).

115

Fowler PW et al. Insights into the structural nature of the transition state in the Kir channel gating pathway.
Channels (Austin), 2014 , 8 (551-5).

116

Kumar M et al. Focus on Kir7.1: physiology and channelopathy.
Channels (Austin), 2014 , 8 (488-95).

117

Zapata M et al. Molecular cloning of ion channels in Felis catus that are related to periodic paralyses in man: a contribution to the understanding of the genetic susceptibility to feline neck ventroflexion and paralysis.
Biol Open, 2014 , 3 (785-93).

118

Sang Y et al. Mutational analysis of ABCC8, KCNJ11, GLUD1, HNF4A and GCK genes in 30 Chinese patients with congenital hyperinsulinism.
Endocr. J., 2014 , 61 (901-10).

119

Rouhier MF et al. Pharmacological validation of an inward-rectifier potassium (Kir) channel as an insecticide target in the yellow fever mosquito Aedes aegypti.
PLoS ONE, 2014 , 9 (e100700).

120

Durmaz E et al. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
J Clin Res Pediatr Endocrinol, 2014 , 6 (119-21).

121

Elvira B et al. SPAK and OSR1 dependent down-regulation of murine renal outer medullary K channel ROMK1.
Kidney Blood Press. Res., 2014 , 39 (353-60).

122

Mohnike K et al. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism.
Horm Res Paediatr, 2014 , 81 (156-68).

123

Su C et al. Long-term follow-up and mutation analysis of 27 chinese cases of congenital hyperinsulinism.
Horm Res Paediatr, 2014 , 81 (169-76).

124

Keshavarz P et al. Lack of genetic susceptibility of KCNJ11 E23K polymorphism with risk of type 2 diabetes in an Iranian population.
Endocr. Res., 2014 , 39 (120-5).

125

Sato Y et al. Moderate hypoxia induces β-cell dysfunction with HIF-1-independent gene expression changes.
PLoS ONE, 2014 , 9 (e114868).

126

[To the mechanisms of antiarrhythmic action of Allapinine].
Bioorg. Khim., 2013 Jan-Feb , 39 (105-16).

127

Lang F et al. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth.
Hormones (Athens), 2013 Apr-Jun , 12 (160-71).

128

Duan X Ion Channels, Channelopathies, and Tooth Formation.
J. Dent. Res., 2013 Sep 27 , ().

129

Chai Y et al. Molecular etiology of hearing impairment associated with nonsyndromic enlarged vestibular aqueduct in East China.
Am. J. Med. Genet. A, 2013 Sep , 161 (2226-33).

130

Cross JH et al. Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome.
Dev Med Child Neurol, 2013 Sep , 55 (846-56).

131

Pathare G et al. A molecular update on Pseudohypoaldosteronism type II.
Am. J. Physiol. Renal Physiol., 2013 Oct 9 , ().

132

Yang H et al. Compromised potassium recycling in the cochlea contributes to conservation of endocochlear potential in a mouse model of age-related hearing loss.
Neurosci. Lett., 2013 Oct 25 , 555 (97-101).

133

Wang Z et al. Regulation of large-conductance Ca2+-activated K+ channels by WNK4 kinase.
Am. J. Physiol., Cell Physiol., 2013 Oct 15 , 305 (C846-53).

134

Al-Agha AE et al. Characterization of the ABCC8 gene mutation and phenotype in patients with congenital hyperinsulinism in western Saudi Arabia.
Saudi Med J, 2013 Oct , 34 (1002-6).

135

Arjona FJ et al. Tissue-specific expression and in vivo regulation of zebrafish orthologues of mammalian genes related to symptomatic hypomagnesemia.
Pflugers Arch., 2013 Oct , 465 (1409-21).

136

Yue P et al. WNK4 inhibits Ca(2+)-activated big-conductance potassium channels (BK) via mitogen-activated protein kinase-dependent pathway.
Biochim. Biophys. Acta, 2013 Oct , 1833 (2101-10).

137

Sherif EM et al. An Egyptian case of congenital hyperinsulinism of infancy due to a novel mutation in KCNJ11 encoding Kir6.2 and response to octreotide.
Acta Diabetol, 2013 Oct , 50 (801-5).

138

Karnes JH et al. Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
Pharmacogenomics J., 2013 Oct , 13 (430-6).

139

Pietrzak-Nowacka M et al. The E23K polymorphism of the KCNJ11gene is associated with lower insulin release in patients with autosomal dominant polycystic kidney disease.
Nefrologia, 2013 Nov 13 , 33 (855-8).

140

Tang H et al. Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one.
Bioorg. Med. Chem. Lett., 2013 Nov 1 , 23 (5829-32).

141

Shimomura K et al. A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1.
Diabetes, 2013 Nov , 62 (3797-806).

142

Fedele F et al. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease.
Basic Res. Cardiol., 2013 Nov , 108 (387).

143

Busiah K et al. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].
Lancet Diabetes Endocrinol, 2013 Nov , 1 (199-207).

144

Shibata S et al. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
Proc. Natl. Acad. Sci. U.S.A., 2013 May 7 , 110 (7838-43).

145

Faletra F et al. Congenital hyperinsulinism: clinical and molecular analysis of a large Italian cohort.
Gene, 2013 May 25 , 521 (160-5).

146

Welling PA Regulation of renal potassium secretion: molecular mechanisms.
Semin. Nephrol., 2013 May , 33 (215-28).

147

Kanakatti Shankar R et al. Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study.
Pediatr Diabetes, 2013 May , 14 (174-80).

148

Mahmood F et al. Generation and validation of a zebrafish model of EAST (epilepsy, ataxia, sensorineural deafness and tubulopathy) syndrome.
Dis Model Mech, 2013 May , 6 (652-60).

149

Jahnavi S et al. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
Clin. Genet., 2013 May , 83 (439-45).

150

Nichols CG et al. KATP channels and cardiovascular disease: suddenly a syndrome.
Circ. Res., 2013 Mar 29 , 112 (1059-72).

151

Faletra F et al. Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.
Gene, 2013 Mar 1 , 516 (122-5).

152

Moritani M et al. Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age.
Pediatr Diabetes, 2013 Mar , 14 (112-20).

153

Kara B et al. KCNJ10 gene mutation in an 8-year-old boy with seizures.
Acta Neurol Belg, 2013 Mar , 113 (75-7).

154

Lorente-Cánovas B et al. Mice deficient in H+-ATPase a4 subunit have severe hearing impairment associated with enlarged endolymphatic compartments within the inner ear.
Dis Model Mech, 2013 Mar , 6 (434-42).

155

Babiker T et al. Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required.
Diabetes Res. Clin. Pract., 2013 Jun , 100 (e63).

156

Hussain S et al. Permanent neonatal diabetes due to a novel insulin signal peptide mutation.
Pediatr Diabetes, 2013 Jun , 14 (299-303).

157

Yorifuji T et al. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism.
Clin. Endocrinol. (Oxf), 2013 Jun , 78 (891-7).

158

Sanda S et al. A SNP in G6PC2 predicts insulin secretion in type 1 diabetes.
Acta Diabetol, 2013 Jun , 50 (459-62).

159

Saxena R et al. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.
Acta Diabetol, 2013 Jun , 50 (451-7).

160

Fretzayas A et al. Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II.
Pediatr Int, 2013 Jun , 55 (371-3).

161

Lang F et al. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
Expert Opin Investig Drugs, 2013 Jun , 22 (701-14).

162

Angsanakul J et al. Scorpion venoms, kidney and potassium.
Toxicon, 2013 Jul 5 , ().

163

Zhang C et al. Src-family protein tyrosine kinase regulates the basolateral K channel in the distal convoluted tubule (DCT) by phosphorylation of KCNJ10.
J. Biol. Chem., 2013 Jul 19 , ().

164

Denton JS et al. Invited Review - Novel Diuretic Targets.
Am. J. Physiol. Renal Physiol., 2013 Jul 17 , ().

165

Frindt G et al. Inhibition of ROMK channels by low extracellular K+ and oxidative stress.
Am. J. Physiol. Renal Physiol., 2013 Jul 15 , 305 (F208-15).

166

Arya VB et al. Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age.
Arch. Dis. Child. Fetal Neonatal Ed., 2013 Jul , 98 (F356-8).

167

Irgens HU et al. Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry.
Diabetologia, 2013 Jul , 56 (1512-9).

168

Fukuda H et al. Replication study for the association of a single-nucleotide polymorphism, rs3746876, within KCNJ15, with susceptibility to type 2 diabetes in a Japanese population.
J. Hum. Genet., 2013 Jul , 58 (490-3).

169

van der Lubbe N et al. Effects of angiotensin II on kinase-mediated sodium and potassium transport in the distal nephron.
Curr. Opin. Nephrol. Hypertens., 2013 Jan , 22 (120-6).

170

Li YY The KCNJ11 E23K gene polymorphism and type 2 diabetes mellitus in the Chinese Han population: a meta-analysis of 6,109 subjects.
Mol. Biol. Rep., 2013 Jan , 40 (141-6).

171

Lang F et al. Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1.
FASEB J., 2013 Jan , 27 (3-12).

172

Hilder TA et al. Conduction and block of inward rectifier K+ channels: predicted structure of a potent blocker of Kir2.1.
Biochemistry, 2013 Feb 5 , 52 (967-74).

173

Cheng CJ et al. Kidney-specific WNK1 regulates sodium reabsorption and potassium secretion in mouse cortical collecting duct.
Am. J. Physiol. Renal Physiol., 2013 Feb 15 , 304 (F397-402).

174

Ronzaud C et al. Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension.
J. Clin. Invest., 2013 Feb 1 , 123 (657-65).

175

Snider KE et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism.
J. Clin. Endocrinol. Metab., 2013 Feb , 98 (E355-63).

176

Siraskar B et al. Downregulation of the renal outer medullary K(+) channel ROMK by the AMP-activated protein kinase.
Pflugers Arch., 2013 Feb , 465 (233-45).

177

Tizioto PC et al. Identification of KCNJ11 as a functional candidate gene for bovine meat tenderness.
Physiol. Genomics, 2013 Dec 15 , 45 (1215-21).

178

Liu L et al. Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes.
Diabetologia, 2013 Dec , 56 (2609-18).

179

Philla KQ et al. Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.
Diabetes Care, 2013 Dec , 36 (e201).

180

Üstün NU et al. A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism -a case report.
Fetal Pediatr Pathol, 2013 Dec , 32 (412-7).

181

Cha SK et al. Flow-induced activation of TRPV5 and TRPV6 channels stimulates Ca(2+)-activated K(+) channel causing membrane hyperpolarization.
Biochim. Biophys. Acta, 2013 Dec , 1833 (3046-53).

182

Versari S et al. The challenging environment on board the International Space Station affects endothelial cell function by triggering oxidative stress through thioredoxin interacting protein overexpression: the ESA-SPHINX experiment.
FASEB J., 2013 Aug 2 , ().

183

Szuts V et al. Altered expression of genes for Kir ion channels in dilated cardiomyopathy.
Can. J. Physiol. Pharmacol., 2013 Aug , 91 (648-56).

184

Cabral PD et al. Less potassium coming out, less sodium going in: phenotyping ROMK knockout rats.
Hypertension, 2013 Aug , 62 (240-1).

185

Zhou X et al. Heterozygous disruption of renal outer medullary potassium channel in rats is associated with reduced blood pressure.
Hypertension, 2013 Aug , 62 (288-94).

186

Amin N et al. Refining genome-wide linkage intervals using a meta-analysis of genome-wide association studies identifies loci influencing personality dimensions.
Eur. J. Hum. Genet., 2013 Aug , 21 (876-82).

187

Fendler W et al. Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion.
Diabetes Care, 2013 Aug , 36 (2311-6).

188

Xu ZD et al. [ABCC8, KCNJ11 and GLUD1 gene mutation analysis in congenital hyperinsulinism pedigree].
Zhonghua Yi Xue Za Zhi, 2013 Apr 9 , 93 (1089-92).

189

Kapoor RR et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
Eur. J. Endocrinol., 2013 Apr , 168 (557-64).

190

Cameron JS et al. Cardiac K(ATP) channel alterations associated with acclimation to hypoxia in goldfish (Carassius auratus L.).
Comp. Biochem. Physiol., Part A Mol. Integr. Physiol., 2013 Apr , 164 (554-64).

191

Falhammar H et al. Thyrotoxic periodic paralysis: clinical and molecular aspects.
Endocrine, 2013 Apr , 43 (274-84).

192

Heo JW et al. Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes mellitus due to an R201H mutation in the KCNJ11 gene: a case report.
Diabetes Res. Clin. Pract., 2013 Apr , 100 (e1-2).

193

Qin LJ et al. Meta-analysis of association of common variants in the KCNJ11-ABCC8 region with type 2 diabetes.
Genet. Mol. Res., 2013 , 12 (2990-3002).

194

Parrock S et al. KCNJ10 mutations display differential sensitivity to heteromerisation with KCNJ16.
Nephron Physiol, 2013 , 123 (7-14).

195

Stawerska R et al. Frequency of the E23K polymorphism of the KCNJ11 gene in children born small for gestational age and its influence on auxological and metabolic parameters in the prepubertal period.
J. Pediatr. Endocrinol. Metab., 2013 , 26 (457-62).

196

Yang W et al. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child.
J. Pediatr. Endocrinol. Metab., 2013 , 26 (591-4).

197

Khoriati D et al. Prematurity, macrosomia, hyperinsulinaemic hypoglycaemia and a dominant ABCC8 gene mutation.
BMJ Case Rep, 2013 , 2013 ().

198

Zschüntzsch J et al. Heterologous expression of a glial Kir channel (KCNJ10) in a neuroblastoma spinal cord (NSC-34) cell line.
Physiol Res, 2013 , 62 (95-105).

199

Hu J et al. Unique mechanism of the interaction between honey bee toxin TPNQ and rKir1.1 potassium channel explored by computational simulations: insights into the relative insensitivity of channel towards animal toxins.
PLoS ONE, 2013 , 8 (e67213).

200

Raphemot R et al. High-throughput screening for small-molecule modulators of inward rectifier potassium channels.
J Vis Exp, 2013 , ().

201

Itoh S et al. DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas.
J. Pediatr. Endocrinol. Metab., 2013 , 26 (143-6).

202

Danquah I et al. The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case-control study.
BMC Med. Genet., 2013 , 14 (96).

203

Lin D et al. Inhibition of miR-205 impairs the wound-healing process in human corneal epithelial cells by targeting KIR4.1 (KCNJ10).
Invest. Ophthalmol. Vis. Sci., 2013 , 54 (6167-78).

204

Landa P et al. Lack of significant association between mutations of KCNJ10 or FOXI1 and SLC26A4 mutations in Pendred syndrome/enlarged vestibular aqueducts.
BMC Med. Genet., 2013 , 14 (85).

205

Yang W et al. KCNJ11 in-frame 15-bp deletion leading to glibenclamide-responsive neonatal diabetes mellitus in a Chinese child.
J. Pediatr. Endocrinol. Metab., 2013 , 26 (743-6).

206

McTaggart JS et al. Gain-of-function mutations in the K(ATP) channel (KCNJ11) impair coordinated hand-eye tracking.
PLoS ONE, 2013 , 8 (e62646).

207

Sogno Valin P et al. Genetic analysis of Italian patients with congenital hyperinsulinism of infancy.
Horm Res Paediatr, 2013 , 79 (236-42).

208

Lin YW et al. Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with infancy-onset diabetes and a mild form of intermediate DEND: a battle between K(ATP) gain of channel activity and loss of channel expression.
PLoS ONE, 2013 , 8 (e63758).

209

Zdebik AA et al. Epilepsy in kcnj10 morphant zebrafish assessed with a novel method for long-term EEG recordings.
PLoS ONE, 2013 , 8 (e79765).

210

Kota SK et al. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
Diabetes Metab Syndr, 2012 Jan-Mar , 6 (54-8).

211

Odgerel Z et al. Genetic variants in potassium channels are associated with type 2 diabetes in a Mongolian population.
J Diabetes, 2012 Sep , 4 (238-42).

212

Kim JJ et al. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes.
Clin. Endocrinol. (Oxf), 2012 Sep , 77 (439-45).

213

Fraser CS et al. Amino acid properties may be useful in predicting clinical outcome in patients with Kir6.2 neonatal diabetes.
Eur. J. Endocrinol., 2012 Sep , 167 (417-21).

214

Shah RP et al. Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas.
Diabetes Care, 2012 Oct , 35 (2086-8).

215

Ragia G et al. Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated type 2 diabetic patients.
Diabetes Res. Clin. Pract., 2012 Oct , 98 (119-24).

216

Yang L et al. Interactions of external K+ and internal blockers in a weak inward-rectifier K+ channel.
J. Gen. Physiol., 2012 Nov , 140 (529-40).

217

Scholl UI et al. SeSAME/EAST syndrome--phenotypic variability and delayed activity of the distal convoluted tubule.
Pediatr. Nephrol., 2012 Nov , 27 (2081-90).

218

Mtiraoui N et al. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.
Diabetes Metab., 2012 Nov , 38 (444-9).

219

Tang H et al. Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.
ACS Med Chem Lett, 2012 May 10 , 3 (367-72).

220

Frindt G et al. Effects of insulin on Na and K transporters in the rat CCD.
Am. J. Physiol. Renal Physiol., 2012 May , 302 (F1227-33).

221

Gong B et al. The effect of KCNJ11 polymorphism on the risk of type 2 diabetes: a global meta-analysis based on 49 case-control studies.
DNA Cell Biol., 2012 May , 31 (801-10).

222

Ko JM et al. E23K polymorphism of the KCNJ11 gene in Korean children with type 1 diabetes.
World J Pediatr, 2012 May , 8 (169-72).

223

Flanagan S et al. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
Pediatr Diabetes, 2012 May , 13 (285-9).

224

Gonen MS et al. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population.
Arch. Med. Res., 2012 May , 43 (317-23).

225

Troncoso Brindeiro CM et al. Tempol prevents altered K(+) channel regulation of afferent arteriolar tone in diabetic rat kidney.
Hypertension, 2012 Mar , 59 (657-64).

226

Mak CM et al. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
Diagn. Mol. Pathol., 2012 Mar , 21 (56-9).

227

Tavira B et al. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus.
Mol. Genet. Metab., 2012 Mar , 105 (525-7).

228

Lang VY et al. Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
Pharmacogenet. Genomics, 2012 Mar , 22 (206-14).

229

Sackin H et al. Residues at the outer mouth of Kir1.1 determine K-dependent gating.
Biophys. J., 2012 Jun 20 , 102 (2742-50).

230

Jain V et al. Permanent neonatal diabetes caused by a novel mutation.
Indian Pediatr, 2012 Jun , 49 (486-8).

231

Gaal Z et al. Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases.
Diabetes Care, 2012 Jun , 35 (e40).

232

Chen K et al. Screening of SLC26A4, FOXI1, KCNJ10, and GJB2 in bilateral deafness patients with inner ear malformation.
Otolaryngol Head Neck Surg, 2012 Jun , 146 (972-8).

233

Rubio-Cabezas O et al. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life.
Pediatr Diabetes, 2012 Jun , 13 (322-5).

234

Udagawa T et al. Inwardly rectifying potassium channel Kir4.1 is localized at the calyx endings of vestibular afferents.
Neuroscience, 2012 Jul 26 , 215 (209-16).

235

Lin DH et al. Protein phosphatase 1 modulates the inhibitory effect of With-no-Lysine kinase 4 on ROMK channels.
Am. J. Physiol. Renal Physiol., 2012 Jul 1 , 303 (F110-9).

236

Ooi HL et al. Three cases of permanent neonatal diabetes mellitus: genotypes and management outcome.
Singapore Med J, 2012 Jul , 53 (e142-4).

237

Okamoto K et al. Inhibition of glucose-stimulated insulin secretion by KCNJ15, a newly identified susceptibility gene for type 2 diabetes.
Diabetes, 2012 Jul , 61 (1734-41).

238

Rosengren AH et al. Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes.
Diabetes, 2012 Jul , 61 (1726-33).

239

Huang PT et al. Protein kinase C mediated pH(i)-regulation of ROMK1 channels via a phosphatidylinositol-4,5-bisphosphate-dependent mechanism.
J Mol Model, 2012 Jul , 18 (2929-41).

240

Wang SY et al. [Neonatal diabetes mellitus caused by KCNJ11 mutation: a case report].
Zhongguo Dang Dai Er Ke Za Zhi, 2012 Jan , 14 (73-5).

241

Yang L et al. Association between KCNJ11 gene polymorphisms and risk of type 2 diabetes mellitus in East Asian populations: a meta-analysis in 42,573 individuals.
Mol. Biol. Rep., 2012 Jan , 39 (645-59).

242

Fatehi M et al. The ATP-sensitive K(+) channel ABCC8 S1369A type 2 diabetes risk variant increases MgATPase activity.
Diabetes, 2012 Jan , 61 (241-9).

243

Brown D et al. Molecular Mechanisms of Acid-Base Sensing by the Kidney.
, 2012 Feb 23 , ().

244

Yang L et al. Ion selectivity and current saturation in inward-rectifier K+ channels.
J. Gen. Physiol., 2012 Feb , 139 (145-57).

245

Okamoto T et al. A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.
Eur. J. Pediatr., 2012 Feb , 171 (401-4).

246

Zhang W et al. Characterization of the R162W Kir7.1 mutation associated with Snowflake vitreoretinopathy.
Am. J. Physiol., Cell Physiol., 2012 Dec 19 , ().

247

Gamboa-Meléndez MA et al. Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population.
Diabetes, 2012 Dec , 61 (3314-21).

248

Mohamed Z et al. Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management.
J Clin Res Pediatr Endocrinol, 2012 Dec , 4 (169-81).

249

Klupa T et al. Monogenic models: what have the single gene disorders taught us?
Curr. Diab. Rep., 2012 Dec , 12 (659-66).

250

Battaglia D et al. Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation.
Pediatr Diabetes, 2012 Dec , 13 (656-60).

251

Robertson JL et al. Multi-ion distributions in the cytoplasmic domain of inward rectifier potassium channels.
Biophys. J., 2012 Aug 8 , 103 (434-43).

252

Rines AK et al. A new pROM king for the mitoK(ATP) dance: ROMK takes the lead.
Circ. Res., 2012 Aug 3 , 111 (392-3).

253

Foster DB et al. Mitochondrial ROMK channel is a molecular component of mitoK(ATP).
Circ. Res., 2012 Aug 3 , 111 (446-54).

254

Felix JP et al. The Inwardly Rectifying Potassium Channel Kir1.1: Development of Functional Assays to Identify and Characterize Channel Inhibitors.
Assay Drug Dev Technol, 2012 Aug 10 , ().

255

Iwata M et al. Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals.
Diabetes Care, 2012 Aug , 35 (1763-70).

256

Habeb AM et al. Permanent neonatal diabetes: different aetiology in Arabs compared to Europeans.
Arch. Dis. Child., 2012 Aug , 97 (721-3).

257

Oztekin O et al. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
J Perinatol, 2012 Aug , 32 (645-7).

258

Cirello V et al. Molecular and functional studies of 4 candidate loci in Pendred syndrome and nonsyndromic hearing loss.
Mol. Cell. Endocrinol., 2012 Apr 4 , 351 (342-50).

259

Abbasi F et al. Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.
Mol Diagn Ther, 2012 Apr 1 , 16 (109-14).

260

Fang Q et al. Genetic background of Prop1(df) mutants provides remarkable protection against hypothyroidism-induced hearing impairment.
J. Assoc. Res. Otolaryngol., 2012 Apr , 13 (173-84).

261

Fanciullo L et al. Sulfonylurea-responsive neonatal diabetes mellitus diagnosed through molecular genetics in two children and in one adult after a long period of insulin treatment.
Acta Biomed, 2012 Apr , 83 (56-61).

262

Klee P et al. A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation.
Diabetes Metab., 2012 Apr , 38 (179-82).

263

Lee BH et al. Genetic basis of Bartter syndrome in Korea.
Nephrol. Dial. Transplant., 2012 Apr , 27 (1516-21).

264

Barajas-Martinez H et al. Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8.
Heart Rhythm, 2012 Apr , 9 (548-55).

265

Javorsky M et al. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.
Eur. J. Intern. Med., 2012 Apr , 23 (245-9).

266

Huang CL Regulation of ion channels by secreted klotho.
Adv. Exp. Med. Biol., 2012 , 728 (100-6).

267

Fatima N et al. Promoter DNA methylation regulates murine SUR1 (Abcc8) and SUR2 (Abcc9) expression in HL-1 cardiomyocytes.
PLoS ONE, 2012 , 7 (e41533).

268

Houtman MJ et al. Experimental Mapping of the Canine KCNJ2 and KCNJ12 Gene Structures and Functional Analysis of the Canine K(IR)2.2 ion Channel.
Front Physiol, 2012 , 3 (9).

269

Bonnefond A et al. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.
PLoS ONE, 2012 , 7 (e37423).

270

Dupont J et al. Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas.
J. Pediatr. Endocrinol. Metab., 2012 , 25 (367-70).

271

Morris LM et al. Mouse middle ear ion homeostasis channels and intercellular junctions.
PLoS ONE, 2012 , 7 (e39004).

272

Zurolo E et al. Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β.
J Neuroinflammation, 2012 , 9 (280).

273

Adalsteinsson BT et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements.
PLoS ONE, 2012 , 7 (e46705).

274

Winkler G et al. [Pharmacogenetics of insulin secretagogue antidiabetics].
Orv Hetil, 2011 Oct 9 , 152 (1651-60).

275

Henquin JC et al. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.
J. Clin. Invest., 2011 Oct 3 , 121 (3932-42).

276

Kapoor RR et al. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations.
Diabetologia, 2011 Oct , 54 (2575-83).

277

Iafusco D et al. No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes.
Diabetologia, 2011 Oct , 54 (2736-8).

278

He W et al. Acid secretion-associated translocation of KCNJ15 in gastric parietal cells.
Am. J. Physiol. Gastrointest. Liver Physiol., 2011 Oct , 301 (G591-600).

279

Glaser B et al. ABCC8 mutation allele frequency in the Ashkenazi Jewish population and risk of focal hyperinsulinemic hypoglycemia.
Genet. Med., 2011 Oct , 13 (891-4).

280

Burge JA et al. Novel Insights into the Pathomechanisms of Skeletal Muscle Channelopathies.
, 2011 Nov 15 , ().

281

Wang T Renal outer medullary potassium channel knockout models reveal thick ascending limb function and dysfunction.
, 2011 Nov 1 , ().

282

Haj-Yasein NN et al. Evidence that compromised K+ spatial buffering contributes to the epileptogenic effect of mutations in the human Kir4.1 gene (KCNJ10).
Glia, 2011 Nov , 59 (1635-42).

283

Liu W et al. Role of NKCC in BK channel-mediated net K⁺ secretion in the CCD.
Am. J. Physiol. Renal Physiol., 2011 Nov , 301 (F1088-97).

284

Joshi R et al. Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene.
World J Pediatr, 2011 Nov , 7 (371-2).

285

Russo C et al. Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea.
Diabetes Res. Clin. Pract., 2011 Nov , 94 (e50-2).

286

Edvinsson JM et al. Kir4.1 K (+) channels are regulated by external cations.
, 2011 May 1 , 5 ().

287

Banerjee I et al. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.
Eur. J. Endocrinol., 2011 May , 164 (733-40).

288

Mercer S et al. Identification of SLC26A4 mutations in patients with hearing loss and enlarged vestibular aqueduct using high-resolution melting curve analysis.
Genet Test Mol Biomarkers, 2011 May , 15 (365-8).

289

Frindt G et al. Conservation of Na+ versus K+ by the rat cortical collecting duct.
, 2011 Mar 30 , ().

290

Hoorn EJ et al. The WNK Kinase Network Regulating Sodium, Potassium, and Blood Pressure.
, 2011 Mar 24 , ().

291

Sackin H et al. Modulation of Kir1.1 inactivation by extracellular Ca and Mg.
Biophys. J., 2011 Mar 2 , 100 (1207-15).

292

Abbas L et al. Functional and developmental expression of a zebrafish Kir1.1 (ROMK) potassium channel homologue Kcnj1.
J. Physiol. (Lond.), 2011 Mar 15 , 589 (1489-503).

293

Vangipurapu J et al. Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men.
Diabetologia, 2011 Mar , 54 (563-71).

294

Ioannou YS et al. KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients.
Pediatr Diabetes, 2011 Mar , 12 (133-7).

295

Cheng CJ et al. Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1.
J. Am. Soc. Nephrol., 2011 Mar , 22 (460-71).

296

Paulais M et al. Renal phenotype in mice lacking the Kir5.1 (Kcnj16) K+ channel subunit contrasts with that observed in SeSAME/EAST syndrome.
Proc. Natl. Acad. Sci. U.S.A., 2011 Jun 21 , 108 (10361-6).

297

Männikkö R et al. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
Diabetes, 2011 Jun , 60 (1813-22).

298

Nieves-Rivera F et al. Neonatal diabetes mellitus: description of two Puerto Rican children with KCNJ11 activating gene mutation.
P R Health Sci J, 2011 Jun , 30 (87-9).

299

Lin DH et al. MicroRNA 802 stimulates ROMK channels by suppressing caveolin-1.
J. Am. Soc. Nephrol., 2011 Jun , 22 (1087-98).

300

Park SE et al. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
Eur. J. Endocrinol., 2011 Jun , 164 (919-26).

301

MacMullen CM et al. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1.
Diabetes, 2011 Jun , 60 (1797-804).

302

Flanagan SE et al. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
Clin. Genet., 2011 Jun , 79 (582-7).

303

Fila M et al. Inhibition of K+ secretion in the distal nephron in nephrotic syndrome: possible role of albuminuria.
J. Physiol. (Lond.), 2011 Jul 15 , 589 (3611-21).

304

Sergouniotis PI et al. Recessive mutations in KCNJ13, encoding an inwardly rectifying potassium channel subunit, cause leber congenital amaurosis.
Am. J. Hum. Genet., 2011 Jul 15 , 89 (183-90).

305

Sicca F et al. Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1.
Neurobiol. Dis., 2011 Jul , 43 (239-47).

306

Russo L et al. Permanent diabetes during the first year of life: multiple gene screening in 54 patients.
Diabetologia, 2011 Jul , 54 (1693-701).

307

Shen Q et al. No association between the KCNH1, KCNJ10 and KCNN3 genes and schizophrenia in the Han Chinese population.
Neurosci. Lett., 2011 Jan 3 , 487 (61-5).

308

Winther SA et al. [The effect of aldosterone A on renal potassium excretion].
Ugeskr. Laeg., 2011 Jan 10 , 173 (126-9).

309

Ješić MM et al. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
Diabetes Res. Clin. Pract., 2011 Jan , 91 (e1-3).

310

Qubbaj W et al. First successful application of preimplantation genetic diagnosis and haplotyping for congenital hyperinsulinism.
Reprod. Biomed. Online, 2011 Jan , 22 (72-9).

311

Bhave G et al. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel.
Mol. Pharmacol., 2011 Jan , 79 (42-50).

312

Yorifuji T et al. Molecular and clinical analysis of Japanese patients with persistent congenital hyperinsulinism: predominance of paternally inherited monoallelic mutations in the KATP channel genes.
J. Clin. Endocrinol. Metab., 2011 Jan , 96 (E141-5).

313

Loechner KJ et al. Congenital hyperinsulinism and glucose hypersensitivity in homozygous and heterozygous carriers of Kir6.2 (KCNJ11) mutation V290M mutation: K(ATP) channel inactivation mechanism and clinical management.
Diabetes, 2011 Jan , 60 (209-17).

314

Saint-Martin C et al. KATP channel mutations in congenital hyperinsulinism.
Semin. Pediatr. Surg., 2011 Feb , 20 (18-22).

315

Yue P et al. Angiotensin II diminishes the effect of SGK1 on the WNK4-mediated inhibition of ROMK1 channels.
Kidney Int., 2011 Feb , 79 (423-31).

316

Hoover RS Angiotensin II: a candidate for an aldosterone-independent mediator of potassium preservation during volume depletion.
Kidney Int., 2011 Feb , 79 (377-9).

317

Alper SL et al. Native and recombinant Slc26a3 (downregulated in adenoma, Dra) do not exhibit properties of 2Cl-/1HCO3- exchange.
Am. J. Physiol., Cell Physiol., 2011 Feb , 300 (C276-86).

318

Furukawa F et al. Potassium excretion through ROMK potassium channel expressed in gill mitochondrion-rich cells of Mozambique tilapia.
, 2011 Dec 28 , ().

319

Edvinsson JM et al. Potassium-dependent activation of Kir4.2 K⁺ channels.
J. Physiol. (Lond.), 2011 Dec 15 , 589 (5949-63).

320

Boodram LG et al. Association of the KCNJ11 variant E23K with type 2 diabetes in Indo-Trinidadians.
West Indian Med J, 2011 Dec , 60 (604-7).

321

Greeley SA et al. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
Curr. Diab. Rep., 2011 Dec , 11 (519-32).

322

Cheng CJ et al. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis.
J. Biol. Chem., 2011 Aug 5 , 286 (27425-35).

323

Zhuang J et al. WNK4 kinase inhibits Maxi K channel activity by a kinase-dependent mechanism.
Am. J. Physiol. Renal Physiol., 2011 Aug , 301 (F410-9).

324

Duan RF et al. Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6.2 gene) polymorphisms in Chinese Han hypertensive patients.
Acta Pharmacol. Sin., 2011 Aug , 32 (1078-84).

325

Sharma A et al. A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels.
Clin. Exp. Nephrol., 2011 Aug , 15 (572-6).

326

Thompson DA et al. Altered electroretinograms in patients with KCNJ10 mutations and EAST syndrome.
J. Physiol. (Lond.), 2011 Apr 1 , 589 (1681-9).

327

Powell PD et al. In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy.
Diabetes, 2011 Apr , 60 (1223-8).

328

Bandulik S et al. The salt-wasting phenotype of EAST syndrome, a disease with multifaceted symptoms linked to the KCNJ10 K+ channel.
Pflugers Arch., 2011 Apr , 461 (423-35).

329

Trapp S et al. Respiratory responses to hypercapnia and hypoxia in mice with genetic ablation of Kir5.1 (Kcnj16).
Exp. Physiol., 2011 Apr , 96 (451-9).

330

Pappa KI et al. Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population.
Gynecol. Endocrinol., 2011 Apr , 27 (267-72).

331

Urbanová M et al. DNA analysis of renal electrolyte transporter genes among patients suffering from Bartter and Gitelman syndromes: summary of mutation screening.
Folia Biol. (Praha), 2011 , 57 (65-73).

332

Wang Y et al. Association of KCNJ11 with impaired glucose regulation in essential hypertension.
Genet. Mol. Res., 2011 , 10 (1111-9).

333

Chen CP et al. Mosaic supernumerary r(1)(p13.2q23.3) in a 10-year-old girl with epilepsy facial asymmetry psychomotor retardation kyphoscoliosis dermatofibrosarcoma and multiple exostoses.
Genet. Couns., 2011 , 22 (273-80).

334

Verheul JC et al. [Congenital hyperinsulinism in the north-east Netherlands. Clinical features and DNA diagnostics in 22 children].
Ned Tijdschr Geneeskd, 2011 , 155 (A3343).

335

Cheung CY et al. The KCNJ11 E23K polymorphism and progression of glycaemia in Southern Chinese: a long-term prospective study.
PLoS ONE, 2011 , 6 (e28598).

336

Renigunta A et al. The glycolytic enzymes glyceraldehyde 3-phosphate dehydrogenase and enolase interact with the renal epithelial K+ channel ROMK2 and regulate its function.
Cell. Physiol. Biochem., 2011 , 28 (663-72).

337

Oçal G et al. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
J. Pediatr. Endocrinol. Metab., 2011 , 24 (1019-23).

338

Siklar Z et al. Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.
J. Pediatr. Endocrinol. Metab., 2011 , 24 (1077-80).

339

Sang Y et al. AV59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child.
J. Pediatr. Endocrinol. Metab., 2011 , 24 (763-6).

340

Jeck N et al. Loop disorders: insights derived from defined genotypes.
Nephron Physiol, 2011 , 118 (p7-14).

341

Kaunisto K et al. [From injections to pills--neonatally diagnosed diabetes of mother and baby].
Duodecim, 2011 , 127 (559-62).

342

Freudenthal B et al. KCNJ10 mutations disrupt function in patients with EAST syndrome.
Nephron Physiol, 2011 , 119 (p40-8).

343

Paynter JJ et al. Random mutagenesis screening indicates the absence of a separate H(+)-sensor in the pH-sensitive Kir channels.
Channels (Austin), 2010 Sep-Oct , 4 (390-7).

344

Lovisolo SM et al. Congenital hyperinsulinism in Brazilian neonates: a study of histology, KATP channel genes, and proliferation of β cells.
Pediatr. Dev. Pathol., 2010 Sep-Oct , 13 (375-84).

345

Lang F et al. SGK, renal function and hypertension.
J. Nephrol., 2010 Nov-Dec , 23 Suppl 16 (S124-9).

346

Ille J et al. [Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2]
Lijec Vjesn, 2010 Mar-Apr , 132 (90-3).

347

Al-Mahdi M et al. Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.
Ann Saudi Med, 2010 Mar-Apr , 30 (162-4).

348

Wagner CA New roles for renal potassium channels.
J. Nephrol., 2010 Jan-Feb , 23 (5-8).

349

Tang X et al. Variable loss of Kir4.1 channel function in SeSAME syndrome mutations.
Biochem. Biophys. Res. Commun., 2010 Sep 3 , 399 (537-41).

350

Inyushin M et al. Potassium channel activity and glutamate uptake are impaired in astrocytes of seizure-susceptible DBA/2 mice.
Epilepsia, 2010 Sep , 51 (1707-13).

351

Bennett K et al. Pancreatic β-cell KATP channels: Hypoglycaemia and hyperglycaemia.
Rev Endocr Metab Disord, 2010 Sep , 11 (157-63).

352

Edghill EL et al. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
Rev Endocr Metab Disord, 2010 Sep , 11 (193-8).

353

Jonard L et al. Screening of SLC26A4, FOXI1 and KCNJ10 genes in unilateral hearing impairment with ipsilateral enlarged vestibular aqueduct.
Int. J. Pediatr. Otorhinolaryngol., 2010 Sep , 74 (1049-53).

354

Wang WH et al. Regulation and function of potassium channels in aldosterone-sensitive distal nephron.
Curr. Opin. Nephrol. Hypertens., 2010 Sep , 19 (463-70).

355

Puricelli E et al. Long-term follow-up of patients with Bartter syndrome type I and II.
Nephrol. Dial. Transplant., 2010 Sep , 25 (2976-81).

356

Hadchouel J et al. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.
Proc. Natl. Acad. Sci. U.S.A., 2010 Oct 19 , 107 (18109-14).

357

D'Adamo MC et al. Genetic inactivation of KCNJ16 identifies Kir5.1 as an important determinant of neuronal PCO2/pH sensitivity.
, 2010 Nov 3 , ().

358

Renigunta A et al. Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function.
, 2010 Nov 16 , ().

359

Sala-Rabanal M et al. Molecular mechanisms of EAST/SeSAME syndrome mutations in Kir4.1 (KCNJ10).
J. Biol. Chem., 2010 Nov 12 , 285 (36040-8).

360

Cotsapas C et al. Expression analysis of loci associated with type 2 diabetes in human tissues.
Diabetologia, 2010 Nov , 53 (2334-9).

361

Bellanne-Chantelot C et al. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
J. Med. Genet., 2010 Nov , 47 (752-9).

362

Hugill A et al. A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.
Diabetologia, 2010 Nov , 53 (2352-6).

363

Furgeson SB et al. Mechanisms of type I and type II pseudohypoaldosteronism.
J. Am. Soc. Nephrol., 2010 Nov , 21 (1842-5).

364

Bogdanović R et al. A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency.
Pediatr. Nephrol., 2010 Nov , 25 (2363-8).

365

Vieira TC et al. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.
Pediatr Diabetes, 2010 Nov , 11 (505-8).

366

Vendramini MF et al. Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene.
Arq Bras Endocrinol Metabol, 2010 Nov , 54 (682-4).

367

Sackin H et al. A conserved arginine near the filter of Kir1.1 controls Rb/K selectivity.
, 2010 May 6 , 4 ().

368

Klupa T et al. Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up.
Diabetes Technol. Ther., 2010 May , 12 (387-91).

369

Khadilkar VV et al. KCNJ11 activating mutation in an Indian family with remitting and relapsing diabetes.
Indian J Pediatr, 2010 May , 77 (551-4).

370

Mohamadi A et al. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
Pediatr Diabetes, 2010 May , 11 (203-7).

371

Bhave G et al. Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities.
Future Med Chem, 2010 May , 2 (757-74).

372

Lu M et al. Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct.
Proc. Natl. Acad. Sci. U.S.A., 2010 Mar 30 , 107 (6082-7).

373

Summers KM et al. Mutations at KCNQ1 and an unknown locus cause long QT syndrome in a large Australian family: implications for genetic testing.
Am. J. Med. Genet. A, 2010 Mar , 152A (613-21).

374

Bantel C et al. Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener.
Anesthesiology, 2010 Mar , 112 (623-30).

375

Yu M et al. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.
Clin. Pharmacol. Ther., 2010 Mar , 87 (330-5).

376

Lang F et al. Significance of SGK1 in the regulation of neuronal function.
, 2010 Jun 7 , ().

377

Njølstad PR et al. [Progress in diabetes genetics]
Tidsskr. Nor. Laegeforen., 2010 Jun 3 , 130 (1145-9).

378

Kobayashi T et al. Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.
Neuropsychopharmacology, 2010 Jun , 35 (1560-9).

379

Wang ZJ et al. Decrease in dietary K intake stimulates the generation of superoxide anions in the kidney and inhibits K secretory channels in the CCD.
Am. J. Physiol. Renal Physiol., 2010 Jun , 298 (F1515-22).

380

Wambach JA et al. Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation.
Pediatr Diabetes, 2010 Jun , 11 (286-8).

381

López-Izquierdo A et al. Thiopental inhibits function of different inward rectifying potassium channel isoforms by a similar mechanism.
Eur. J. Pharmacol., 2010 Jul 25 , 638 (33-41).

382

Clark RH et al. Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin.
Science, 2010 Jul 23 , 329 (458-61).

383

Ilamaran V et al. Persistent hyperinsulinemic hypoglycemia of infancy due to homozygous KCNJ11 (T294M) mutation.
Indian J Pediatr, 2010 Jul , 77 (803-4).

384

Gupta V et al. A validation study of type 2 diabetes-related variants of the TCF7L2, HHEX, KCNJ11, and ADIPOQ genes in one endogamous ethnic group of north India.
Ann. Hum. Genet., 2010 Jul , 74 (361-8).

385

Carrisoza-Gaytán R et al. Potassium secretion by voltage-gated potassium channel Kv1.3 in the rat kidney.
Am. J. Physiol. Renal Physiol., 2010 Jul , 299 (F255-64).

386

Rosenhouse-Dantsker A et al. Comparative analysis of cholesterol sensitivity of Kir channels: Role of the CD loop.
Channels (Austin), 2010 Jan 20 , 4 ().

387

Okamoto K et al. Identification of KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus.
Am. J. Hum. Genet., 2010 Jan , 86 (54-64).

388

Glukhov AV et al. Differential K(ATP) channel pharmacology in intact mouse heart.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (152-60).

389

Zhang H et al. Cardiac sarcolemmal K(ATP) channels: Latest twists in a questing tale!
J. Mol. Cell. Cardiol., 2010 Jan , 48 (71-5).

390

Heuser K et al. Variants of the genes encoding AQP4 and Kir4.1 are associated with subgroups of patients with temporal lobe epilepsy.
Epilepsy Res., 2010 Jan , 88 (55-64).

391

Serratrice G et al. [Potassium channelopathies and Morvan's syndromes].
Bull. Acad. Natl. Med., 2010 Feb , 194 (391-406; discussion 406-7).

392

Meyer TE et al. Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.
Cancer Epidemiol. Biomarkers Prev., 2010 Feb , 19 (558-65).

393

Shimomura K et al. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue.
Diabet. Med., 2010 Feb , 27 (225-9).

394

van de Bunt M et al. From genetic association to molecular mechanism.
Curr. Diab. Rep., 2010 Dec , 10 (452-66).

395

Yang SS et al. Generation and analysis of the thiazide-sensitive Na+ -Cl- cotransporter (Ncc/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome.
Hum. Mutat., 2010 Dec , 31 (1304-15).

396

Fang L et al. Hypertension resistance polymorphisms in ROMK (Kir1.1) alter channel function by different mechanisms.
Am. J. Physiol. Renal Physiol., 2010 Dec , 299 (F1359-64).

397

Yang L et al. Magnesium modulates ROMK channel-mediated potassium secretion.
J. Am. Soc. Nephrol., 2010 Dec , 21 (2109-16).

398

Williams DM et al. Molecular basis of decreased Kir4.1 function in SeSAME/EAST syndrome.
J. Am. Soc. Nephrol., 2010 Dec , 21 (2117-29).

399

Gupta V et al. Population structure of Aggarwals of north India as revealed by molecular markers.
Genet Test Mol Biomarkers, 2010 Dec , 14 (781-5).

400

Frindt G et al. Effects of dietary K on cell-surface expression of renal ion channels and transporters.
, 2010 Aug 11 , ().

401

Reichold M et al. KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function.
Proc. Natl. Acad. Sci. U.S.A., 2010 Aug 10 , 107 (14490-5).

402

Klupa T et al. The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy.
J. Clin. Endocrinol. Metab., 2010 Aug , 95 (3599-604).

403

Zlatkovic-Lindor J et al. ATP-Sensitive K(+) Channel-Deficient Dilated Cardiomyopathy Proteome Remodeled by Embryonic Stem Cell Therapy.
Stem Cells, 2010 Aug , 28 (1355-67).

404

Chauhan G et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians.
Diabetes, 2010 Aug , 59 (2068-74).

405

Flanagan SE et al. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.
Genet Test Mol Biomarkers, 2010 Aug , 14 (533-7).

406

Kochar IP et al. Transient Neonatal Diabetes due to Kcnj11 Mutation.
Indian Pediatr, 2010 Apr 7 , 47 (359-60).

407

Paulson QX et al. Effects of body weight and alcohol consumption on insulin sensitivity.
Nutr J, 2010 , 9 (14).

408

Noczynska A et al. [Three-year observation of permanent neonatal diabetes]
Pediatr Endocrinol Diabetes Metab, 2010 , 16 (50-4).

409

Kim S et al. Changes in the sodium and potassium transporters in the course of chronic renal failure.
Nephron Physiol, 2010 , 115 (p31-41).

410

Kumaran A et al. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks.
Horm Res Paediatr, 2010 , 73 (287-92).

411

Raja M et al. Dissimilarity in the channel intrinsic stability among the bacterial KcsA and the inwardly rectifying potassium channel ROMK1.
Biochimie, 2009 Nov-Dec , 91 (1426-33).

412

Fallen K et al. The Kir channel immunoglobulin domain is essential for Kir1.1 (ROMK) thermodynamic stability, trafficking and gating.
Channels (Austin), 2009 Jan-Feb , 3 (57-68).

413

Yue P et al. Src family protein tyrosine kinase (PTK) modulates the effect of SGK1 and WNK4 on ROMK channels.
Proc. Natl. Acad. Sci. U.S.A., 2009 Sep 1 , 106 (15061-6).

414

Lin CM et al. Chronic renal failure in a boy with classic Bartter's syndrome due to a novel mutation in CLCNKB coding for the chloride channel.
Eur. J. Pediatr., 2009 Sep , 168 (1129-33).

415

Lin DH et al. POSH stimulates the ubiquitination and the clathrin-independent endocytosis of ROMK1 channels.
J. Biol. Chem., 2009 Oct 23 , 284 (29614-24).

416

Wang F et al. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population.
Chin. Med. J., 2009 Oct 20 , 122 (2477-82).

417

Reyes S et al. Targeted disruption of K(ATP) channels aggravates cardiac toxicity in cocaine abuse.
Clin Transl Sci, 2009 Oct , 2 (361-5).

418

Welling PA et al. A comprehensive guide to the ROMK potassium channel: form and function in health and disease.
Am. J. Physiol. Renal Physiol., 2009 Oct , 297 (F849-63).

419

Hamming KS et al. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.
Diabetes, 2009 Oct , 58 (2419-24).

420

Dvoryanchikov G et al. Inward rectifier channel, ROMK, is localized to the apical tips of glial-like cells in mouse taste buds.
J. Comp. Neurol., 2009 Nov 10 , 517 (spc1).

421

Dvoryanchikov G et al. Inward rectifier channel, ROMK, is localized to the apical tips of glial-like cells in mouse taste buds.
J. Comp. Neurol., 2009 Nov 1 , 517 (1-14).

422

Fang L et al. The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney.
J. Clin. Invest., 2009 Nov , 119 (3278-89).

423

Lang F et al. Targeting SGK1 in diabetes.
Expert Opin. Ther. Targets, 2009 Nov , 13 (1303-11).

424

Gach A et al. Neonatal diabetes in a child positive for islet cell antibodies at onset and Kir6.2 activating mutation.
Diabetes Res. Clin. Pract., 2009 Nov , 86 (e25-7).

425

Lewis LM et al. High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1.
Mol. Pharmacol., 2009 Nov , 76 (1094-103).

426

Batra CM et al. Transient neonatal diabetes due to activating mutation in the ABCC8 gene encoding SUR1.
Indian J Pediatr, 2009 Nov , 76 (1169-72).

427

Bockenhauer D et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations.
N. Engl. J. Med., 2009 May 7 , 360 (1960-70).

428

Liu Z et al. Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase.
J. Biol. Chem., 2009 May 1 , 284 (12198-206).

429

Brochard K et al. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.
Nephrol. Dial. Transplant., 2009 May , 24 (1455-64).

430

Holstein A et al. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.
Horm. Metab. Res., 2009 May , 41 (387-90).

431

Sandal T et al. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
Clin. Genet., 2009 May , 75 (440-8).

432

James C et al. The genetic basis of congenital hyperinsulinism.
J. Med. Genet., 2009 May , 46 (289-99).

433

Yang T et al. Mutations of KCNJ10 together with mutations of SLC26A4 cause digenic nonsyndromic hearing loss associated with enlarged vestibular aqueduct syndrome.
Am. J. Hum. Genet., 2009 May , 84 (651-7).

434

Fujimoto W et al. Niflumic acid-sensitive ion channels play an important role in the induction of glucose-stimulated insulin secretion by cyclic AMP in mice.
Diabetologia, 2009 May , 52 (863-72).

435

Fodstad H et al. Effects of mineralocorticoid and K+ concentration on K+ secretion and ROMK channel expression in a mouse cortical collecting duct cell line.
Am. J. Physiol. Renal Physiol., 2009 May , 296 (F966-75).

436

Wang WH et al. Regulation of potassium (K) handling in the renal collecting duct.
Pflugers Arch., 2009 May , 458 (157-68).

437

Winkler M et al. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
J. Biol. Chem., 2009 Mar 13 , 284 (6752-62).

438

Zou SB et al. Role of potassium channel gene Kcnj10 in ethanol preference in C57bl/6J and DBA/2J mice.
Alcohol. Clin. Exp. Res., 2009 Mar , 33 (394-9).

439

Cheng WW et al. KirBac1.1: it's an inward rectifying potassium channel.
J. Gen. Physiol., 2009 Mar , 133 (295-305).

440

Zlatkovic J et al. Proteomic profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome.
Proteomics, 2009 Mar , 9 (1314-25).

441

Wagner VM et al. Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy.
Eur. J. Pediatr., 2009 Mar , 168 (359-61).

442

Chistiakov DA et al. Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes.
, 2009 Mar , 46 (43-9).

443

Zaks-Makhina E et al. Specific and slow inhibition of the kir2.1 K+ channel by gambogic acid.
J. Biol. Chem., 2009 Jun 5 , 284 (15432-8).

444

Lauridsen MH et al. [Diabetes in infants may be treated with sulfonylurea as a replacement for insulin]
Ugeskr. Laeg., 2009 Jun 1 , 171 (1923-4).

445

Hartemann-Heurtier A et al. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.
Diabetes Metab., 2009 Jun , 35 (233-5).

446

Delvecchio M et al. Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: impact of low compliance to the gluten free diet.
Diabetes Res. Clin. Pract., 2009 Jun , 84 (332-4).

447

Furutani K et al. Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel.
Mol. Pharmacol., 2009 Jun , 75 (1287-95).

448

Taneja TK et al. Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism.
Hum. Mol. Genet., 2009 Jul 1 , 18 (2400-13).

449

Zhou D et al. The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population.
J. Hum. Genet., 2009 Jul , 54 (433-5).

450

Cha SK et al. Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho.
Mol. Pharmacol., 2009 Jul , 76 (38-46).

451

Craig TJ et al. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
J. Clin. Endocrinol. Metab., 2009 Jul , 94 (2551-7).

452

Nikolac N et al. Metabolic control in type 2 diabetes is associated with sulfonylurea receptor-1 (SUR-1) but not with KCNJ11 polymorphisms.
Arch. Med. Res., 2009 Jul , 40 (387-92).

453

Takeuchi F et al. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population.
Diabetes, 2009 Jul , 58 (1690-9).

454

Rodan AR et al. Distal potassium handling based on flow modulation of maxi-K channel activity.
Curr. Opin. Nephrol. Hypertens., 2009 Jul , 18 (350-5).

455

Xiao X et al. Transfer from insulin to sulfonylurea treatment in a chinese patient with permanent neonatal diabetes mellitus due to a KCNJ11 R201H mutation.
Horm. Metab. Res., 2009 Jul , 41 (580-2).

456

Ting WH et al. Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus.
J. Pediatr. Endocrinol. Metab., 2009 Jul , 22 (661-7).

457

Pawelczyk M et al. Analysis of gene polymorphisms associated with K ion circulation in the inner ear of patients susceptible and resistant to noise-induced hearing loss.
Ann. Hum. Genet., 2009 Jul , 73 (411-21).

458

Mustapha M et al. Deafness and permanently reduced potassium channel gene expression and function in hypothyroid Pit1dw mutants.
J. Neurosci., 2009 Jan 28 , 29 (1212-23).

459

Nelson TJ et al. KCNJ11 knockout morula re-engineered by stem cell diploid aggregation.
Philos. Trans. R. Soc. Lond., B, Biol. Sci., 2009 Jan 27 , 364 (269-76).

460

Schild-Hay LJ et al. Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells.
Cancer Res., 2009 Feb 1 , 69 (1150-5).

461

Kapoor RR et al. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia.
, 2009 Feb , 5 (101-12).

462

Tabara Y et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.
Diabetes, 2009 Feb , 58 (493-8).

463

Frindt G et al. Dietary K regulates ROMK channels in connecting tubule and cortical collecting duct of rat kidney.
Am. J. Physiol. Renal Physiol., 2009 Feb , 296 (F347-54).

464

Kobayashi T et al. Inhibitory effects of the antiepileptic drug ethosuximide on G protein-activated inwardly rectifying K+ channels.
Neuropharmacology, 2009 Feb , 56 (499-506).

465

Flanagan SE et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
Hum. Mutat., 2009 Feb , 30 (170-80).

466

Stechman MJ et al. Genetic causes of hypercalciuric nephrolithiasis.
Pediatr. Nephrol., 2009 Dec , 24 (2321-32).

467

Reyes S et al. KATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response.
Hum. Genet., 2009 Dec , 126 (779-89).

468

Valamparampil JJ et al. Clinical profile and etiology of diabetes mellitus with onset at less than 6 months of age.
Kaohsiung J. Med. Sci., 2009 Dec , 25 (656-62).

469

Shi M et al. The EAST syndrome and KCNJ10 mutations.
N. Engl. J. Med., 2009 Aug 6 , 361 (630; author reply 630-1).

470

Sackin H et al. An intersubunit salt bridge near the selectivity filter stabilizes the active state of Kir1.1.
Biophys. J., 2009 Aug 19 , 97 (1058-66).

471

Yoshida T et al. Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.
Int. J. Mol. Med., 2009 Aug , 24 (233-46).

472

Kumaraguru J et al. Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect.
Diabetes Care, 2009 Aug , 32 (1428-30).

473

Scholl UI et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10.
Proc. Natl. Acad. Sci. U.S.A., 2009 Apr 7 , 106 (5842-7).

474

Demontis GC et al. Selective Hcn1 channels inhibition by ivabradine in mouse rod photoreceptors.
Invest. Ophthalmol. Vis. Sci., 2009 Apr , 50 (1948-55).

475

Judge SI et al. Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection: ischemic/hypoxic/anoxic injury and general anesthetics.
Expert Opin Ther Pat, 2009 Apr , 19 (433-60).

476

Ruete MC et al. Altered renal expression of Na(+) transporters and ROMK in protein-deprived rats.
Nephron Physiol, 2009 , 111 (p17-29).

477

Kobayashi T et al. Pregnenolone sulfate potentiates the inwardly rectifying K channel Kir2.3.
PLoS ONE, 2009 , 4 (e6311).

478

Lee JR et al. Structural changes in the cytoplasmic pore of the Kir1.1 channel during pHi-gating probed by FRET.
J. Biomed. Sci., 2009 , 16 (29).

479

Boulpaep E Protein-protein interactions among ion channels regulate ion transport in the kidney.
Bull. Mem. Acad. R. Med. Belg., 2009 , 164 (133-41; discussion 141-2).

480

Thorsby PM et al. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.
Scand. J. Clin. Lab. Invest., 2009 , 69 (282-7).

481

Hu C et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.
PLoS ONE, 2009 , 4 (e7643).

482

Christopoulos P et al. Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome.
Gynecol. Endocrinol., 2008 Sep , 24 (486-90).

483

Begum-Hasan J et al. Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy--a three-year follow-up.
J. Pediatr. Endocrinol. Metab., 2008 Sep , 21 (895-903).

484

Sun QF et al. Differential gene expression profiles of normal human parotid and submandibular glands.
, 2008 Sep , 14 (500-9).

485

Staník J et al. Coincidence of a novel KCNJ11 missense variant R365H with a paternally inherited 6q24 duplication in a patient with transient neonatal diabetes.
Diabetes Care, 2008 Sep , 31 (1736-7).

486

Yan Q et al. Female ROMK null mice manifest more severe Bartter II phenotype on renal function and higher PGE2 production.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008 Sep , 295 (R997-R1004).

487

Yang D et al. Expression of inwardly rectifying potassium channel subunits in native human retinal pigment epithelium.
Exp. Eye Res., 2008 Sep , 87 (176-83).

488

Murthy M et al. The acidic motif of WNK4 is crucial for its interaction with the K channel ROMK.
Biochem. Biophys. Res. Commun., 2008 Oct 31 , 375 (651-4).

489

Støy J et al. Diagnosis and treatment of neonatal diabetes: a United States experience.
, 2008 Oct , 9 (450-9).

490

Lee CH et al. Functional and structural characterization of PKA-mediated pHi gating of ROMK1 channels.
J. Mol. Graph. Model., 2008 Oct , 27 (332-41).

491

Herder C et al. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies.
Horm. Metab. Res., 2008 Oct , 40 (722-6).

492

Feng Y et al. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients.
Diabetes Care, 2008 Oct , 31 (1939-44).

493

Koster JC et al. DEND mutation in Kir6.2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP channel.
Biophys. J., 2008 Nov 15 , 95 (4689-97).

494

Klose A et al. 1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) selectively inhibits Kir3 and BK channels in a phospholipase C-independent fashion.
Mol. Pharmacol., 2008 Nov , 74 (1203-14).

495

Zhang W et al. WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway.
Am. J. Physiol. Renal Physiol., 2008 Nov , 295 (F1472-84).

496

Della Manna T et al. Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene.
Arq Bras Endocrinol Metabol, 2008 Nov , 52 (1350-5).

497

Gaulton KJ et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes.
Diabetes, 2008 Nov , 57 (3136-44).

498

Ji W et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation.
Nat. Genet., 2008 May , 40 (592-9).

499

Lee CH et al. Gabapentin activates ROMK1 channels by a protein kinase A (PKA)-dependent mechanism.
Br. J. Pharmacol., 2008 May , 154 (216-25).

500

Arbizu Lostao J et al. [18F-fluoro-L-DOPA PET-CT imaging combined with genetic analysis for optimal classification and treatment in a child with severe congenital hyperinsulinism]
, 2008 May , 68 (481-5).

501

Sonalker PA et al. Chronic noradrenaline increases renal expression of NHE-3, NBC-1, BSC-1 and aquaporin-2.
Clin. Exp. Pharmacol. Physiol., 2008 May , 35 (594-600).

502

Lin D et al. Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels.
J. Biol. Chem., 2008 Mar 21 , 283 (7674-81).

503

Slingerland AS et al. Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.
Diabet. Med., 2008 Mar , 25 (277-81).

504

Gurgel LC et al. [Neonatal diabetes mellitus]
, 2008 Mar , 52 (181-7).

505

Koster JC et al. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.
J. Clin. Endocrinol. Metab., 2008 Mar , 93 (1054-61).

506

Omori S et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.
Diabetes, 2008 Mar , 57 (791-5).

507

Zhang Y et al. K restriction inhibits protein phosphatase 2B (PP2B) and suppression of PP2B decreases ROMK channel activity in the CCD.
Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C765-73).

508

Yamamoto Y et al. Immunohistochemical distribution of inwardly rectifying K+ channels in the medulla oblongata of the rat.
J. Vet. Med. Sci., 2008 Mar , 70 (265-71).

509

Klein KM et al. Evaluation of susceptibility loci in an extended pedigree with idiopathic generalized epilepsy.
, 2008 Mar , 10 (13-8).

510

Smith SB et al. Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes.
Pharmacogenet. Genomics, 2008 Mar , 18 (231-41).

511

Tobin MD et al. Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population.
Hypertension, 2008 Jun , 51 (1658-64).

512

Wagner CA et al. Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins.
Am. J. Physiol. Renal Physiol., 2008 Jun , 294 (F1373-80).

513

D'Amato E et al. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
Diabet. Med., 2008 Jun , 25 (651-6).

514

Orío Hernández M et al. [Neonatal diabetes mellitus and KCNJ11 gene mutation: report of a family case]
, 2008 Jun , 68 (602-4).

515

Cantone A et al. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
Am. J. Physiol. Renal Physiol., 2008 Jun , 294 (F1366-72).

516

Bremer AA et al. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
, 2008 Jun , 9 (236-9).

517

Wan J et al. Study of Kir6.2/KCNJ11 gene in a sudden cardiac death pedigree.
Mol. Biol. Rep., 2008 Jun , 35 (119-23).

518

Lee CH et al. PKA-mediated phosphorylation is a novel mechanism for levetiracetam, an antiepileptic drug, activating ROMK1 channels.
Biochem. Pharmacol., 2008 Jul 15 , 76 (225-35).

519

Troncoso Brindeiro CM et al. Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.
Am. J. Physiol. Renal Physiol., 2008 Jul , 295 (F171-8).

520

Lee CH et al. d-Amphetamine inhibits inwardly rectifying potassium channels in Xenopus oocytes expression system.
Neurotoxicology, 2008 Jul , 29 (638-46).

521

de Wet H et al. A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes.
EMBO Rep., 2008 Jul , 9 (648-54).

522

Yamamoto Y et al. Expression of inwardly rectifying K+ channels in the carotid body of rat.
Histol. Histopathol., 2008 Jul , 23 (799-806).

523

Abdulhadi-Atwan M et al. Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence.
Diabetes, 2008 Jul , 57 (1935-40).

524

Bennett AJ et al. No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth.
Diabetologia, 2008 Jan , 51 (82-5).

525

Fischer A et al. KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts.
Diabetes Care, 2008 Jan , 31 (87-9).

526

Yi Y et al. Association between KCNJ11 E23K genotype and cardiovascular and glucose metabolism phenotypes in older men and women.
Exp. Physiol., 2008 Jan , 93 (95-103).

527

Shield JP et al. Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophy.
Diabetes, 2008 Jan , 57 (255-8).

528

Hussain K et al. An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism.
Diabetes, 2008 Jan , 57 (259-63).

529

Singh R et al. Free radical stress-mediated loss of Kcnj10 protein expression in stria vascularis contributes to deafness in Pendred syndrome mouse model.
Am. J. Physiol. Renal Physiol., 2008 Jan , 294 (F139-48).

530

Hejtmancik JF et al. Mutations in KCNJ13 cause autosomal-dominant snowflake vitreoretinal degeneration.
Am. J. Hum. Genet., 2008 Jan , 82 (174-80).

531

Jin Z et al. Spatiotemporal loss of K+ transport proteins in the developing cochlear lateral wall of guinea pigs with hereditary deafness.
Eur. J. Neurosci., 2008 Jan , 27 (145-54).

532

Zitron E et al. Kir2.x inward rectifier potassium channels are differentially regulated by adrenergic alpha1A receptors.
J. Mol. Cell. Cardiol., 2008 Jan , 44 (84-94).

533

Yang D et al. Expression of Kir7.1 and a novel Kir7.1 splice variant in native human retinal pigment epithelium.
Exp. Eye Res., 2008 Jan , 86 (81-91).

534

Flechtner I et al. Neonatal hyperglycaemia and abnormal development of the pancreas.
Best Pract. Res. Clin. Endocrinol. Metab., 2008 Feb , 22 (17-40).

535

Hsieh SC et al. Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus.
Rheumatology (Oxford), 2008 Feb , 47 (150-7).

536

Alsmadi O et al. Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes.
Diabetes Metab. Res. Rev., 2008 Feb , 24 (137-40).

537

Ranjith N et al. Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction.
, 2008 Fall , 6 (209-14).

538

Flagg TP et al. Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1.
Circ. Res., 2008 Dec 5 , 103 (1458-65).

539

Robertson JL et al. Long-pore electrostatics in inward-rectifier potassium channels.
J. Gen. Physiol., 2008 Dec , 132 (613-32).

540

Spector DA et al. The ROMK potassium channel is present in mammalian urinary tract epithelia and muscle.
Am. J. Physiol. Renal Physiol., 2008 Dec , 295 (F1658-65).

541

Damaj L et al. Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism.
J. Clin. Endocrinol. Metab., 2008 Dec , 93 (4941-7).

542

Lybaert P et al. KATP channel subunits are expressed in the epididymal epithelium in several mammalian species.
Biol. Reprod., 2008 Aug , 79 (253-61).

543

He YY et al. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.
Acta Pharmacol. Sin., 2008 Aug , 29 (983-9).

544

Pinney SE et al. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
J. Clin. Invest., 2008 Aug , 118 (2877-86).

545

Wang HR et al. Domains of WNK1 kinase in the regulation of ROMK1.
Am. J. Physiol. Renal Physiol., 2008 Aug , 295 (F438-45).

546

Lin YW et al. Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.
J. Biol. Chem., 2008 Apr 4 , 283 (9146-56).

547

Polak M et al. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.
Diabetes, 2008 Apr , 57 (1115-9).

548

Flanagan SE et al. Identification of mutations in the Kir6.2 subunit of the K(ATP) channel.
Methods Mol. Biol., 2008 , 491 (235-45).

549

Shah JH et al. Alanine in HI: a silent mutation cries out!
Adv. Exp. Med. Biol., 2008 , 614 (145-50).

550

Gach A et al. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes]
, 2008 , 14 (45-9).

551

Zmysłowska A et al. [The rare syndromic forms of monogenic diabetes in childhood]
, 2008 , 14 (41-3).

552

Abreu N et al. Hemodynamic parameters during normal and hypertensive pregnancy in rats: evaluation of renal salt and water transporters.
Hypertens Pregnancy, 2008 , 27 (49-63).

553

Papadopoulos N et al. Possible roles of the weakly inward rectifying k+ channel Kir4.1 (KCNJ10) in the pre-Bötzinger complex.
Adv. Exp. Med. Biol., 2008 , 605 (109-13).

554

Zou J et al. Progressive hearing loss in mice with a mutated vitamin D receptor gene.
Audiol. Neurootol., 2008 , 13 (219-30).

555

Nanazashvili M et al. Moving the pH gate of the Kir1.1 inward rectifier channel.
Channels (Austin), 2007 Jan-Feb , 1 (21-8).

556

Greer RM et al. Genotype-phenotype associations in patients with severe hyperinsulinism of infancy.
Pediatr. Dev. Pathol., 2007 Jan-Feb , 10 (25-34).

557

Shimomura K et al. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
Neurology, 2007 Sep 25 , 69 (1342-9).

558

Parton LE et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity.
Nature, 2007 Sep 13 , 449 (228-32).

559

Lucarini N et al. Genetic polymorphisms and idiopathic generalized epilepsies.
Pediatr. Neurol., 2007 Sep , 37 (157-64).

560

Rieg T et al. The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion.
Kidney Int., 2007 Sep , 72 (566-73).

561

Sansom SC et al. Two channels for one job.
Kidney Int., 2007 Sep , 72 (529-30).

562

Grimm PR et al. BK channels in the kidney.
Curr. Opin. Nephrol. Hypertens., 2007 Sep , 16 (430-6).

563

Yan FF et al. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
Diabetes, 2007 Sep , 56 (2339-48).

564

Härtel K et al. Calcium influx mediated by the inwardly rectifying K+ channel Kir4.1 (KCNJ10) at low external K+ concentration.
Cell Calcium, 2007 Sep , 42 (271-80).

565

Ohno Y et al. Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors.
Brain Res., 2007 Oct 31 , 1178 (44-51).

566

Fenton RA et al. Mouse models and the urinary concentrating mechanism in the new millennium.
Physiol. Rev., 2007 Oct , 87 (1083-112).

567

Letha S et al. Permanent neonatal diabetes due to KCNJ11 gene mutation.
, 2007 Oct , 74 (947-9).

568

Sumnik Z et al. Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome).
Diabet. Med., 2007 Oct , 24 (1176-8).

569

Däublin G et al. Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.
Diabetes Care, 2007 Oct , 30 (e104).

570

Jin Y et al. PGE2 inhibits apical K channels in the CCD through activation of the MAPK pathway.
Am. J. Physiol. Renal Physiol., 2007 Oct , 293 (F1299-307).

571

Eng B et al. Characterization of a long-term rat mTAL cell line.
Am. J. Physiol. Renal Physiol., 2007 Oct , 293 (F1413-22).

572

Lang F et al. Functional significance of channels and transporters expressed in the inner ear and kidney.
Am. J. Physiol., Cell Physiol., 2007 Oct , 293 (C1187-208).

573

Suzuki S et al. Molecular basis of neonatal diabetes in Japanese patients.
J. Clin. Endocrinol. Metab., 2007 Oct , 92 (3979-85).

574

de Wet H et al. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
Proc. Natl. Acad. Sci. U.S.A., 2007 Nov 27 , 104 (18988-92).

575

Mlynarski W et al. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.
, 2007 Nov , 3 (640-5).

576

Flechtner I et al. [Neonatal diabetes: a disease linked to multiple mechanisms]
, 2007 Nov , 14 (1356-65).

577

Nichols CG et al. beta-cell hyperexcitability: from hyperinsulinism to diabetes.
, 2007 Nov , 9 Suppl 2 (81-8).

578

Tarasov AI et al. Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.
, 2007 Nov , 9 Suppl 2 (46-55).

579

Patch AM et al. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period.
, 2007 Nov , 9 Suppl 2 (28-39).

580

Gurgel LC et al. Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function.
Diabetes Care, 2007 Nov , 30 (e108).

581

Qi L et al. Gene-gene interactions between HNF4A and KCNJ11 in predicting Type 2 diabetes in women.
Diabet. Med., 2007 Nov , 24 (1187-91).

582

Zhang X et al. Inhibitor of growth 4 (ING4) is up-regulated by a low K intake and suppresses renal outer medullary K channels (ROMK) by MAPK stimulation.
Proc. Natl. Acad. Sci. U.S.A., 2007 May 29 , 104 (9517-22).

583

Yang SS et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.
Cell Metab., 2007 May , 5 (331-44).

584

Lettre G et al. Genetic model testing and statistical power in population-based association studies of quantitative traits.
Genet. Epidemiol., 2007 May , 31 (358-62).

585

Richardson CC et al. Low levels of glucose transporters and K+ATP channels in human pancreatic beta cells early in development.
Diabetologia, 2007 May , 50 (1000-5).

586

Edghill EL et al. Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings.
J. Clin. Endocrinol. Metab., 2007 May , 92 (1773-7).

587

Landau Z et al. Sulfonylurea-responsive diabetes in childhood.
J. Pediatr., 2007 May , 150 (553-5).

588

Wangemann P et al. Loss of cochlear HCO3- secretion causes deafness via endolymphatic acidification and inhibition of Ca2+ reabsorption in a Pendred syndrome mouse model.
Am. J. Physiol. Renal Physiol., 2007 May , 292 (F1345-53).

589

Ring AM et al. An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis.
Proc. Natl. Acad. Sci. U.S.A., 2007 Mar 6 , 104 (4025-9).

590

Haider S et al. Molecular dynamics simulations of inwardly rectifying (Kir) potassium channels: a comparative study.
Biochemistry, 2007 Mar 27 , 46 (3643-52).

591

Wei Y et al. Angiotensin II inhibits the ROMK-like small conductance K channel in renal cortical collecting duct during dietary potassium restriction.
J. Biol. Chem., 2007 Mar 2 , 282 (6455-62).

592

Huang C et al. Interaction of the Ca2+-sensing receptor with the inwardly rectifying potassium channels Kir4.1 and Kir4.2 results in inhibition of channel function.
Am. J. Physiol. Renal Physiol., 2007 Mar , 292 (F1073-81).

593

Friedland DR et al. Potassium channel gene expression in the rat cochlear nucleus.
Hear. Res., 2007 Jun , 228 (31-43).

594

Barber TM et al. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
Eur. J. Hum. Genet., 2007 Jun , 15 (679-84).

595

Kobayashi T et al. Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes.
Toxicol In Vitro, 2007 Jun , 21 (656-64).

596

Sackin H et al. External K activation of Kir1.1 depends on the pH gate.
Biophys. J., 2007 Jul 15 , 93 (L14-6).

597

Flanagan SE et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.
Diabetes, 2007 Jul , 56 (1930-7).

598

Muzyamba M et al. Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.
Clin. Endocrinol. (Oxf), 2007 Jul , 67 (115-24).

599

Rica I et al. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
Diabet. Med., 2007 Jul , 24 (707-13).

600

Scherer D et al. Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.
Naunyn Schmiedebergs Arch. Pharmacol., 2007 Jul , 375 (311-22).

601

Babilonia E et al. Role of gp91phox -containing NADPH oxidase in mediating the effect of K restriction on ROMK channels and renal K excretion.
J. Am. Soc. Nephrol., 2007 Jul , 18 (2037-45).

602

Girirajan S et al. 17p11.2p12 triplication and del(17)q11.2q12 in a severely affected child with dup(17)p11.2p12 syndrome.
Clin. Genet., 2007 Jul , 72 (47-58).

603

Malecki MT et al. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
Diabetes Care, 2007 Jan , 30 (147-9).

604

Domenighetti AA et al. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
J. Mol. Cell. Cardiol., 2007 Jan , 42 (63-70).

605

Chang HK et al. Charges in the cytoplasmic pore control intrinsic inward rectification and single-channel properties in Kir1.1 and Kir2.1 channels.
J. Membr. Biol., 2007 Feb , 215 (181-93).

606

Bryan J et al. ABCC8 and ABCC9: ABC transporters that regulate K+ channels.
Pflugers Arch., 2007 Feb , 453 (703-18).

607

Florez JC et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
Diabetes, 2007 Feb , 56 (531-6).

608

Masia R et al. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Diabetes, 2007 Feb , 56 (328-36).

609

Koo BK et al. Polymorphisms of KCNJ11 (Kir6.2 gene) are associated with Type 2 diabetes and hypertension in the Korean population.
Diabet. Med., 2007 Feb , 24 (178-86).

610

Wabitsch M et al. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
Diabet. Med., 2007 Dec , 24 (1393-9).

611

Dai AI et al. Idiopathic epilepsy of childhood and potassium ion channels.
, 2007 Aug , 57 (415-8).

612

Kim MS et al. Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2.
J. Korean Med. Sci., 2007 Aug , 22 (616-20).

613

Nozu K et al. A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism.
Pediatr. Nephrol., 2007 Aug , 22 (1219-23).

614

Biagiotti L et al. Identification of two novel frameshift mutations in the KCNJ11 gene in two Italian patients affected by Congenital Hyperinsulinism of Infancy.
Exp. Mol. Pathol., 2007 Aug , 83 (59-64).